Literature DB >> 28675256

[Prevalence and risk factors for periventricular leukomalacia in preterm infants. A systematic review].

G J Romero-Guzman1, F Lopez-Munoz2.   

Abstract

INTRODUCTION: There is a huge disparity in the description of the prevalence and risk factors of periventricular leukomalacia in preterm infants. AIMS: To describe and compare, through a systematic review of the literature, the prevalence of periventricular leukomalacia in preterm infants, as well as to determine the main risk factors associated with its presentation. SUBJECTS AND METHODS: A systematic review was conducted consulting multiple databases of the last 20 years. The search terms were: periventricular leukomalacia, prevalence, risk factors and premature birth. We included all studies that mention or led to the prevalence of periventricular leukomalacia and those that referred to its risk factors.
RESULTS: Of the 209 studies identified, we selected 107 studies in which the prevalence of periventricular leukomalacia was mentioned or the risk factors were described. A stratified analysis was performed for the diagnostic technique and gestational age, in addition to a narrative synthesis. Ultrasound detected a prevalence of 14.7% and magnetic resonance of 32.8%. Prevalence in children under 28 weeks was 39.6%; 27.4% in children under 32 weeks and 7.3% in children under 37 weeks. Risk factors include gestational age, intrauterine infection, premature rupture of membranes and chorioamnionitis.
CONCLUSIONS: The prevalence of periventricular leukomalacia in preterm infants is heterogeneous, increases according to the degree of prematurity and is better detected by magnetic resonance. There are multiple factors related to its presentation, the main factor is gestational age.

Entities:  

Mesh:

Year:  2017        PMID: 28675256

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  8 in total

1.  Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes.

Authors:  Laura Gomez; Diane Boegler; Chloé Epiard; Layli Alin; Julie Arata-Bardet; Yvan Caspar; Thierry Debillon; Françoise Stanke-Labesque; Elodie Gautier-Veyret
Journal:  Antimicrob Agents Chemother       Date:  2022-04-25       Impact factor: 5.938

Review 2.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

3.  Impact of peri-intraventricular haemorrhage and periventricular leukomalacia in the neurodevelopment of preterms: A systematic review and meta-analysis.

Authors:  Juliana Wendling Gotardo; Nathalia de Freitas Valle Volkmer; Guilherme Pucci Stangler; Alícia Dorneles Dornelles; Betânia Barreto de Athayde Bohrer; Clarissa Gutierrez Carvalho
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

4.  Human Wharton's Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways.

Authors:  Marianne S Joerger-Messerli; Gierin Thomi; Valérie Haesler; Irene Keller; Patricia Renz; Daniel V Surbek; Andreina Schoeberlein
Journal:  Front Cell Dev Biol       Date:  2021-03-23

5.  Association between morphine exposure and impaired brain development on term-equivalent age brain magnetic resonance imaging in very preterm infants.

Authors:  Mountasser M Al-Mouqdad; Dima Z Jamjoom; Roya Huseynova; Thanaa M Khalil; Yasmeen S Asfour; Bushra A Albeshri; Nadia A Basodan; Fuddah Assiri; Suzan S Asfour
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

Review 6.  Preterm white matter injury: ultrasound diagnosis and classification.

Authors:  Thais Agut; Ana Alarcon; Fernando Cabañas; Marco Bartocci; Miriam Martinez-Biarge; Sandra Horsch
Journal:  Pediatr Res       Date:  2020-03       Impact factor: 3.756

7.  Knockdown of G protein-coupled receptor-17 (GPR17) facilitates the regeneration and repair of myelin sheath post-periventricular leukomalacia (PVL).

Authors:  Liufang He; Hui Yang; Jinxing Feng; Tingyan Wei; Yong Huang; Xueli Zhang; Zhangxing Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Serum glial fibrillary acidic protein as a biomarker of brain injury in premature neonates.

Authors:  Dimitra Metallinou; Grigorios Karampas; Georgia Nyktari; Nicoletta Iacovidou; Katerina Lykeridou; Demetrios Rizos
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.